BIOMAT Database Logo BIOMAT Database Logo

Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study. 1990

J D McCracken, and L M Janaki, and J J Crowley, and S A Taylor, and P G Giri, and G B Weiss, and W Gordon, and L H Baker, and A Mansouri, and J P Kuebler
Brooke Army Medical Center, Ft Sam Houston, TX.

The Southwest Oncology Group (SWOG) has conducted a phase II study to explore the efficacy and toxicity of initial, concurrent use of radiation therapy with cisplatin, etoposide (VP-16), and vincristine in limited-stage small-cell carcinoma of the lung. Two courses of cisplatin, VP-16, and vincristine chemotherapy were given with concurrent radiotherapy (XRT) to the primary tumor to a total dose of 4,500 cGy. Elective brain XRT was given to all patients concurrent with a third course of cisplatin/VP-16 therapy. Consolidation chemotherapy consisting of vincristine, methotrexate, and VP-16 alternating with Adriamycin (doxorubicin; Adria Laboratories, Columbus, OH) and cyclophosphamide, was given for 12 weeks following the initial induction chemotherapy/XRT program. Patients with a complete response had all therapy discontinued. Among 154 eligible patients treated, the complete response rate was 56%, with a partial response rate of 27%. The median survival is 17.5 months with an estimated 30% survival rate at 4 years from initiation of treatment. Combined modality toxicities were acceptable with the predominant toxicity being moderate to severe leukopenia and mild radiation esophagitis. The results of this treatment program appear superior to any previously reported by our group and compare favorably to those in the literature at large.

UI MeSH Term Description Entries
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D005260 Female Females

Related Publications

J D McCracken, and L M Janaki, and J J Crowley, and S A Taylor, and P G Giri, and G B Weiss, and W Gordon, and L H Baker, and A Mansouri, and J P Kuebler
Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small-cell carcinoma of the lung: a Southwest Oncology Group Study.
June 1982, Cancer,
J D McCracken, and L M Janaki, and J J Crowley, and S A Taylor, and P G Giri, and G B Weiss, and W Gordon, and L H Baker, and A Mansouri, and J P Kuebler
Small-cell carcinoma of the lung: combined chemotherapy and radiation: a Southwest Oncology Group study.
February 1978, Annals of internal medicine,
J D McCracken, and L M Janaki, and J J Crowley, and S A Taylor, and P G Giri, and G B Weiss, and W Gordon, and L H Baker, and A Mansouri, and J P Kuebler
Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
October 1994, Japanese journal of clinical oncology,
J D McCracken, and L M Janaki, and J J Crowley, and S A Taylor, and P G Giri, and G B Weiss, and W Gordon, and L H Baker, and A Mansouri, and J P Kuebler
Combination chemotherapy, radiotherapy, and BCG immunotherapy in extensive (metastatic) small cell carcinoma of the lung. A Southwest Oncology Group study.
December 1980, Cancer,
J D McCracken, and L M Janaki, and J J Crowley, and S A Taylor, and P G Giri, and G B Weiss, and W Gordon, and L H Baker, and A Mansouri, and J P Kuebler
Combined treatment with chemotherapy and neutron irradiation for limited non-small-cell lung cancer: a Southwest Oncology Group Study.
November 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J D McCracken, and L M Janaki, and J J Crowley, and S A Taylor, and P G Giri, and G B Weiss, and W Gordon, and L H Baker, and A Mansouri, and J P Kuebler
Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group study.
June 1993, Cancer,
J D McCracken, and L M Janaki, and J J Crowley, and S A Taylor, and P G Giri, and G B Weiss, and W Gordon, and L H Baker, and A Mansouri, and J P Kuebler
Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study.
August 2004, Clinical cancer research : an official journal of the American Association for Cancer Research,
J D McCracken, and L M Janaki, and J J Crowley, and S A Taylor, and P G Giri, and G B Weiss, and W Gordon, and L H Baker, and A Mansouri, and J P Kuebler
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
February 1995, International journal of radiation oncology, biology, physics,
J D McCracken, and L M Janaki, and J J Crowley, and S A Taylor, and P G Giri, and G B Weiss, and W Gordon, and L H Baker, and A Mansouri, and J P Kuebler
Treatment of limited small-cell lung cancer with concurrent etoposide/cisplatin and radiotherapy followed by intensification with high-dose cyclophosphamide: a Southwest Oncology Group study.
March 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J D McCracken, and L M Janaki, and J J Crowley, and S A Taylor, and P G Giri, and G B Weiss, and W Gordon, and L H Baker, and A Mansouri, and J P Kuebler
Simultaneous chemotherapy-radiotherapy with prophylactic cranial irradiation for inoperable adeno and large cell lung carcinoma: a Southwest Oncology Group Study.
September 1988, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!